Science Explorer Back to mapMap
Discussion
Institution · Greater Manchester STEM Centre

Most cited papers from Greater Manchester STEM Centre

Greater Manchester STEM Centre

What are the most cited papers from Greater Manchester STEM Centre?

The most cited paper from Greater Manchester STEM Centre is "Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease" (Denise H. Harold et al., 2009), with 3,422 citations. Next come "Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration" (1,135) and "Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update" (1,033).

Showing 50 of 61 papers. Every paper with more than 10 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease Denise H. Harold et al. · Nature Genetics Open access 6 Sep 2009 3,422
2 Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration Nigel J. Cairns et al. · Acta Neuropathologica Open access 19 Jun 2007 1,135
3 Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update Ian R. Mackenzie et al. · Acta Neuropathologica Open access 18 Nov 2009 1,033
4 Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease Lesley Jones et al. · PLoS ONE Open access 15 Nov 2010 614
5 α‐Synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma Omar M. A. El‐Agnaf, Sultan A. Salem, Katerina E. Paleologou et al. · The FASEB Journal 15 Aug 2003 591
6 A Polymorphism in CALHM1 Influences Ca2+ Homeostasis, Aβ Levels, and Alzheimer's Disease Risk Ute Dreses‐Werringloer et al. · Cell Open access Jun 2008 326
7 Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43 Yvonne S. Davidson, Thomas C. Kelley, Ian R. Mackenzie et al. · Acta Neuropathologica 11 Jan 2007 300
8 King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation К. Ray Chaudhuri, Alexandra Rizos, Claudia Trenkwalder et al. · Movement Disorders Open access 11 Jun 2015 267
9 FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration Hazel Urwin et al. · Acta Neuropathologica Open access 19 May 2010 251
10 Distinct patterns of olfactory impairment in Alzheimer's disease, semantic dementia, frontotemporal dementia, and corticobasal degeneration Simona Luzzi, Julie S. Snowden, David Neary et al. · Neuropsychologia Open access 29 Dec 2006 244
11 Myasthenia gravis: Association of British Neurologists’ management guidelines Jon D. Sussman, Maria Elena Farrugia, Paul Maddison et al. · Practical Neurology Open access 14 May 2015 201
12 Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia Julie S. Snowden, Stuart M. Pickering-Brown, Ian R. Mackenzie et al. · Brain Open access 26 Sep 2006 201
13 Risk for myasthenia gravis maps to a 151 Pro→Ala change in TNIP1 and to human leukocyte antigen‐B*08 Peter K. Gregersen et al. · Annals of Neurology Open access 18 Jul 2012 169
14 Parkinson’s disease: summary of updated NICE guidance G Rogers, Debbie Davies, Joshua Pink et al. · BMJ Open access 27 Jul 2017 115
15 Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer's disease R McNeill, Gillian M. Sare, Murugesan Manoharan et al. · Journal of Neurology Neurosurgery & Psychiatry Open access 3 Oct 2006 110
16 Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial Keith W. Muir et al. · The Lancet Neurology Open access 16 Oct 2024 104
17 A European multicentre survey of impulse control behaviours in Parkinson's disease patients treated with short‐ and long‐acting dopamine agonists Alexandra Rizos, Anna Sauerbier, Angelo Antonini et al. · European Journal of Neurology Open access 11 May 2016 101
18 Calcium‐permeable AMPA receptors are involved in the induction and expression of l‐DOPA‐induced dyskinesia in Parkinson’s disease Christopher Kobylecki, Maria Angela Cenci, Alan R. Crossman et al. · Journal of Neurochemistry Open access 29 Apr 2010 100
19 Mutations in progranulin explain atypical phenotypes with variants in MAPT Stuart M. Pickering-Brown, Matthew Baker, Jennifer M. Gass et al. · Brain 29 Sep 2006 99
20 Sudden unexpected death in epilepsy genetics: Molecular diagnostics and prevention Alica M. Goldman, Elijah Raphael Behr, Christopher Semsarian et al. · Epilepsia Open access 2016 98
21 New aspects on patients affected by dysferlin deficient muscular dystrophy Lars Klinge, A. Aboumousa, M. Eagle et al. · Journal of Neurology Neurosurgery & Psychiatry Open access 14 Jun 2009 98
22 Five cases of new onset refractory status epilepticus (NORSE) syndrome: Outcomes with early immunotherapy Claire Gall, Odai K. Jumma, Rajiv Mohanraj · Seizure Open access 17 Jan 2013 91
23 Dementia lacking distinctive histology (DLDH) revisited Ian R. Mackenzie, Jing Shi, Catherine L. Shaw et al. · Acta Neuropathologica 9 Aug 2006 88
24 Normal and pathogenic variation of RFC1 repeat expansions: implications for clinical diagnosis Natalia Dominik et al. · Brain Open access118 authors 13 Jul 2023 77
25 Genome-Wide Association Study of Late-Onset Myasthenia Gravis: Confirmation of TNFRSF11A and Identification of ZBTB10 and Three Distinct HLA Associations Michael F. Seldin, Omar K. Alkhairy, Annette T. Lee et al. · Molecular Medicine Open access 2015 77
26 Glutamic acid decarboxylase (GAD) antibodies in epilepsy: Diagnostic yield and therapeutic implications James B Lilleker, Viveka Biswas, Rajiv Mohanraj · Seizure Open access 26 Apr 2014 62
27 No consistent evidence for association between mtDNA variants and Alzheimer disease Gavin Hudson et al. · Neurology Open access 23 Mar 2012 53
28 Apolipoprotein E υ4 Allele Frequency in Vascular Dementia Yvonne S. Davidson, Linda J. Gibbons, Nitin B. Purandare et al. · Dementia and Geriatric Cognitive Disorders 2006 53
29 Synergistic antidyskinetic effects of topiramate and amantadine in animal models of Parkinson's disease Christopher Kobylecki, Michael P. Hill, Alan R. Crossman et al. · Movement Disorders 23 Sep 2011 51
30 Selective reduction of soluble Tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study Victoria A. Zhukareva, Sonali Sundarraj, David M. A. Mann et al. · Acta Neuropathologica 25 Jan 2003 51
31 Démence sémantique : réflexions d’un groupe de travail pour des critères de diagnostic en français et la constitution d’une cohorte de patients Olivier Moreaud et al. · Revue Neurologique Apr 2008 41
32 Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP‐17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer’s disease Anna-Maria Shiarli et al. · Neuropathology and Applied Neurobiology 7 Jul 2006 40
33 Interictal electroencephalographic functional network topology in drug‐resistant and well‐controlled idiopathic generalized epilepsy Emily Pegg, Jason R. Taylor, Petroula Laiou et al. · Epilepsia Open access 26 Jan 2021 37
34 VISUAL PATHWAY COMPROMISE AFTER HYDROCOIL TREATMENT OF LARGE OPHTHALMIC ANEURYSMS Gwynedd E. Pickett, Roger D. Laitt, Amit Herwadkar et al. · Neurosurgery Oct 2007 36
35 Periprocedural antithrombotic management for lumbar puncture: Association of British Neurologists clinical guideline Katherine Claire Dodd, Hedley C A Emsley, Michael Desborough et al. · Practical Neurology Open access 28 Aug 2018 35
36 Blood-based near-infrared spectroscopy for the rapid low-cost detection of Alzheimer's disease Maria Paraskevaidi, Camilo L. M. Morais, Daniel L. D. Freitas et al. · The Analyst Open access 2018 34
37 The Association of British Neurologists' myasthenia gravis guidelines Jon D. Sussman, Maria Elena Farrugia, Paul Maddison et al. · Annals of the New York Academy of Sciences 9 Nov 2017 33
38 Evidence for the association of the S100β gene with low cognitive performance and dementia in the elderly J-C Lambert, Stéphanie Ferreira, Jacobijn Gussekloo et al. · Molecular Psychiatry 5 Sep 2002 28
39 Extraventricular neurocytoma of the sellar region Yi Yuen Wang, Tara Kearney, Daniel du Plessis et al. · British Journal of Neurosurgery 28 Nov 2011 28
40 Alternative splicing of AMPA receptor subunits in the 6-OHDA-lesioned rat model of Parkinson's disease and L-DOPA-induced dyskinesia Christopher Kobylecki, Alan R. Crossman, Paula Ravenscroft · Experimental Neurology 26 Jan 2013 27
41 Deletion/Insertion Polymorphism of the Angiotensin‐Converting Enzyme Gene and White Matter Hyperintensities in Dementia: A Pilot Study Nitin B. Purandare, Richard C. Oude Voshaar, Yvonne S. Davidson et al. · Journal of the American Geriatrics Society 18 Jul 2006 26
42 Pituicytoma: a misdiagnosed benign tumour of the posterior pituitary W.A. Thiryayi, K. K. Gnanalingham, H Reid et al. · British Journal of Neurosurgery 2007 25
43 Diffusion-weighted imaging and its relationship to microglial activation in parkinsonian syndromes Christopher Kobylecki, Serena J. Counsell, Nicole Cabanel et al. · Parkinsonism & Related Disorders 18 Feb 2013 24
44 Case report: Severe acute Parkinsonism associated with streptococcal infection and antibasal ganglia antibodies Devin McKee, J.D. Sussman · Movement Disorders 2 Aug 2005 21
45 Further developments with antisense treatment for myasthenia gravis Jon D. Sussman, Zohar Argov, Y. Wirguin et al. · Annals of the New York Academy of Sciences Dec 2012 21
46 Incidental finding of fenestration of the supraclinoid internal carotid artery with appearances on magnetic resonance angiography Andrew Plumb, Amit Herwadkar, Gwynedd E. Pickett · Surgical and Radiologic Anatomy 11 Sep 2009 19
47 Improving the measurement properties of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R): deriving a valid measurement total for the calculation of change Carolyn Anne Young, Amina Chaouch, Christopher J. McDermott et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Open access Mar 2024 17
48 Double origin of the posterior inferior cerebellar artery with findings on conventional and CT angiography Andrew Plumb, Amit Herwadkar, Roger D. Laitt · Surgical and Radiologic Anatomy 10 Dec 2008 17
49 Screening for patients at risk of developing chronic incapacity Chris J. Main, P. J. Watson · Journal of Occupational Rehabilitation Dec 1995 16
50 Clinical aspects of hereditary frontotemporal dementia Anna M. T. Richardson, David Neary · Handbook of clinical neurology Book chapter 2008 16

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.